Room B
Educational session
Date
11.04.2018
Time
14:30 - 16:00
Location
Room B
Chairs
- Juergen Wolf (DE)
- Tony S.K. Mok (HK)
First line for oncogene addicted lung cancer
Educational session
Is PFS still a relevant endpoint for first-line TKIs?
Lecture Time
14:30 - 14:50
Presenter
- Suresh S. Ramalingam (US)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Suresh S. Ramalingam (US)
First line for oncogene addicted lung cancer
Educational session
First vs second vs third generation EGFR TKI
Lecture Time
14:50 - 15:10
Presenter
- Juergen Wolf (DE)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Juergen Wolf (DE)
First line for oncogene addicted lung cancer
Educational session
Key factors that determine the selection of first-line ALK inhibtiors
Lecture Time
15:10 - 15:30
Presenter
- Fiona H. Blackhall (GB)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Fiona H. Blackhall (GB)
First line for oncogene addicted lung cancer
Educational session
The role of first-line combination therapy for oncogene addicted lung cancer
Lecture Time
15:30 - 15:50
Presenter
- Takashi Seto (JP)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
- Takashi Seto (JP)
First line for oncogene addicted lung cancer
Educational session
Q&A
Lecture Time
15:50 - 16:00
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00